<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04690647</url>
  </required_header>
  <id_info>
    <org_study_id>FasiaIliaca</org_study_id>
    <nct_id>NCT04690647</nct_id>
  </id_info>
  <brief_title>The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.</brief_title>
  <official_title>The Efficacy of Ultrasound Guided Suprainguinal Fascia Iliaca Compartment Block for Acute Paint Control After Elective Total Hip Replacement Using Postero-lateral Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Lucas Hospital, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Lucas Hospital, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total hip replacement surgery is one of the most common orthopedic interventions. Proper&#xD;
      anaesthesia and adequate analgesia is one of the key interests of attending anaesthetist.&#xD;
      Recent studies show that ultrasound guided suprainguinal fascia iliaca compartment block may&#xD;
      play a significant role in proper management of pain after these procedures. The aim of this&#xD;
      study was to assess the clinical usefulness and compare different methods of anaesthesia for&#xD;
      total hip replacement surgery via posterolateral approach.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 28, 2018</start_date>
  <completion_date type="Actual">December 20, 2019</completion_date>
  <primary_completion_date type="Actual">December 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption [mg]</measure>
    <time_frame>48 hours</time_frame>
    <description>Postoperative opioid consumption was noted.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid related adverse effects</measure>
    <time_frame>48 hours</time_frame>
    <description>Postoperative incidence of nausea, vomiting, constipation and apnea were noted.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital stay [days]</measure>
    <time_frame>31 days</time_frame>
    <description>Total length of hospital stay was noted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Likert scale</measure>
    <time_frame>31 days</time_frame>
    <description>Likert scale value was noted at the discharge. Value of 1 corresponded with strong dissatisfaction, value of 2 with dissatisfaction, value of 3 with neither satisfaction nor dissatisfaction, value of 4 with satisfaction, value of 5 with strong satisfaction.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Anesthesia, Local</condition>
  <condition>Analgesia</condition>
  <condition>Arthropathy of Hip</condition>
  <arm_group>
    <arm_group_label>Opioid and non opioid postoperative analgesia.</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group of patients with opioid and non opioid based postoperative analgesia without preoperative regional anaesthesia and dexamethasone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regional anaesthesia, opioid and non opioid postoperative analgesia.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group of patients with opioid and non opioid based postoperative analgesia with preoperative regional anaesthesia and without preoperative dexamethasone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regional anaesthesia, dexamethasone, opioid and non opioid postoperative analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group of patients with opioid and non opioid based postoperative analgesia with preoperative regional anaesthesia and dexamethasone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Opioid and non opioid postoperative analgesia.</intervention_name>
    <description>Postoperative analgesia will be based on opioid and non opioid analgesics according to standardised protocol.</description>
    <arm_group_label>Opioid and non opioid postoperative analgesia.</arm_group_label>
    <arm_group_label>Regional anaesthesia, dexamethasone, opioid and non opioid postoperative analgesia</arm_group_label>
    <arm_group_label>Regional anaesthesia, opioid and non opioid postoperative analgesia.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fascia iliaca compartment block</intervention_name>
    <description>Ultrasound guided suprainguinal fascia iliaca compartment block will be performed using 0.375% ropivacaine and 5ug/ml adrenaline according to standardised protocol.</description>
    <arm_group_label>Regional anaesthesia, dexamethasone, opioid and non opioid postoperative analgesia</arm_group_label>
    <arm_group_label>Regional anaesthesia, opioid and non opioid postoperative analgesia.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone will be administered preoperatively in a dose of 0,1 mg/kg.</description>
    <arm_group_label>Regional anaesthesia, dexamethasone, opioid and non opioid postoperative analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-75 years old&#xD;
&#xD;
          -  informed consent to participate in the study&#xD;
&#xD;
          -  ASA score I-III&#xD;
&#xD;
          -  BMI -19-30kg/m2&#xD;
&#xD;
          -  qualified for total hip replacement&#xD;
&#xD;
          -  no contraindication to used anesthesia and drugs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindications to spinal anesthesia and regional blocks&#xD;
&#xD;
          -  previously coexisting chronic pain&#xD;
&#xD;
          -  previously opioids intake&#xD;
&#xD;
          -  BMI&gt;30kg/m2&#xD;
&#xD;
          -  allergy to drugs using during study&#xD;
&#xD;
          -  mental status preventing the usage of patient controlled analgesia pump&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wojciech Gola, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of the Department of Anesthesia and Intensive Care Unit, Saint Lucas Hospital, Konskie, Poland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint Lucas Hospital</name>
      <address>
        <city>Konskie</city>
        <state>Swietokrzyskie</state>
        <zip>20-206</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 4, 2020</study_first_submitted>
  <study_first_submitted_qc>December 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2020</study_first_posted>
  <last_update_submitted>December 27, 2020</last_update_submitted>
  <last_update_submitted_qc>December 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint Lucas Hospital, Poland</investigator_affiliation>
    <investigator_full_name>Wojciech Gola</investigator_full_name>
    <investigator_title>MD, Head of The Department of Anesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Analgesics, Non-Narcotic</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

